SM1
A long-acting incretin receptor agonist studied for incretin signaling and glucose-metabolism research.
Research Overview
SM1 is a long-acting synthetic analog of incretin, acting as an agonist of the incretin receptor. Research models study its role in incretin signaling, glucose-dependent insulin secretion, and energy-homeostasis pathways.
As one of the most extensively studied incretin receptor agonists, it serves as a common comparison standard in metabolic-pathway research.
Specifications
| Compound | SM1 (incretin receptor agonist) |
| Classification | Metabolic research compound |
| Molecular weight | 4,113.58 g/mol |
| Sequence / Form | Synthetic incretin analog |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
